Hinge Health, Inc.
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
HNGE$123.23+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(in thousands, except per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue | $234,970 | $154,211 | $630,094 | $417,134 |
| Cost of revenue | 30,640 | 28,012 | 87,582 | 92,939 |
| Gross profit | 204,330 | 126,199 | 542,512 | 324,195 |
| Operating expenses: | ||||
| Research and development | 37,473 | 31,921 | 101,868 | 335,382 |
| Sales and marketing | 85,241 | 63,520 | 235,451 | 257,464 |
| General and administrative | 31,291 | 36,851 | 82,359 | 304,976 |
| Total operating expenses | 154,005 | 132,292 | 419,678 | 897,822 |
| Income (loss) from operations | 50,325 | (6,093) | 122,834 | (573,627) |
| Other income: | ||||
| Other income, net | 3,392 | 4,455 | 11,255 | 14,147 |
| Net income (loss) before income taxes | 53,717 | (1,638) | 134,089 | (559,480) |
| (Benefit from) provision for income taxes | (3,681) | 206 | (2,128) | 876 |
| Net income (loss) | $57,398 | $(1,844) | $136,217 | $(560,356) |
| Adjustment to reflect deemed contribution from Series D and Series E redeemable convertible preferred stock extinguishment | — | — | — | 104,174 |
| Income allocated to participating securities | — | — | (2,051) | — |
| Net income (loss) attributable to common stockholders | $57,398 | $(1,844) | $134,166 | $(456,182) |
| Net income (loss) attributable to common stockholders per share: | ||||
| Basic | $0.71 | $(0.02) | $1.69 | $(9.88) |
| Diluted | $0.66 | $(0.02) | $1.58 | $(9.88) |
| Weighted average shares used in computing net income (loss) per share attributable to common stockholders: | ||||
| Basic | 80,868 | 78,858 | 79,493 | 46,173 |
| Diluted | 86,526 | 78,858 | 85,073 | 46,173 |
| Net income (loss) | $57,398 | $(1,844) | $136,217 | $(560,356) |
| Other comprehensive income (loss): | ||||
| Unrealized gain (loss) on marketable securities, net of taxes | (557) | 87 | (901) | (15) |
| Comprehensive income (loss) | $56,841 | $(1,757) | $135,316 | $(560,371) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.